Orhan Şencan

Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III ‘Stop and Go' Study Results - A Turkish Oncology Group Trial

Şuayib Yalçın, Rüçhan Uslu, Faysal Dane et al. · Oncology · 2013 · 70 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Inhibitory Effect of 5‐Fluorouracil on Cytochrome P450 2C9 Activity in Cancer Patients

Arzu Gunes, Uğur Çoşkun, Cem Boruban et al. · Basic & Clinical Pharmacology & Toxicology · 2006 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +17

Tamoxifen Inhibits Cytochrome P450 2C9 Activity in Breast Cancer Patients

Melih Cem Börüban, Ümit Yaşar, Melih O. Babaoğlu et al. · Journal of Chemotherapy · 2006 · 30 citations

Medicine, Pharmacokinetics, Pharmacology +11

Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group

Hakan Akbulut, Aytuğ Üner, E Baltali et al. · British Journal of Cancer · 2005 · 26 citations · Full text

Medicine, Oncology, Pharmacology +9

Hemodynamic changes in the early phase of artificially created arteriovenous fistula: color Doppler ultrasonographic findings.

M Kesenci, Suat Fítöz, S Büyükberber et al. · Journal of Ultrasound in Medicine · 1997 · 16 citations

Medicine, Nephrology, Surgery +17